Home›Search›Molecular Therapy Oncology

Molecular Therapy Oncology

Cell Press · United States · Est. 1998

ISSN2950-3299eISSN2950-3299

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Slow · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.79

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.943

Total Worksi

391

Total Citationsi

1,009

2yr Mean Citednessi

2.59

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Molecular Therapy Oncology is an international journal focusing on the development and testing of cancer therapies in pre-clinical and clinical settings. It provides a forum for work in biologic cancer therapies, including viral therapies.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1998

Annual Volume~ 108 articles / year

StatusActive (last: 2026)

Total Publications391

OA Since2023

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~22 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✗ No

📦 Long-term Preservation

Koninklijke BibliotheekPorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Cell Press

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2950-3299 / 2950-3299

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Koninklijke Bibliotheek, Portico, CLOCKSS

❌

Plagiarism detection in place?

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1998

151

912

2024

171

281

2025

152

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

Molecular MedicineQ1

OncologyQ1

Pharmacology (medical)Q1

Subject Classification

Web of Science Categories

Medicine, Research & ExperimentalOncology

Scopus Categories

Pharmacology (medical)Cancer ResearchOncologyMolecular Medicine

Research Topics (OpenAlex)

CAR-T cell therapy researchVirus-based gene therapy researchImmunotherapy and Immune ResponsesImmune Cell Function and InteractionCancer Research and TreatmentsViral Infectious Diseases and Gene Expression in InsectsCancer Immunotherapy and BiomarkersMonoclonal and Polyclonal Antibodies ResearchRNA Interference and Gene DeliveryCRISPR and Genetic Engineering

Frequently asked questions about Molecular Therapy Oncology

Is Molecular Therapy Oncology a predatory journal?

PubScope has no integrity flags on record for Molecular Therapy Oncology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Molecular Therapy Oncology?

Molecular Therapy Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.59.

Is Molecular Therapy Oncology indexed in Scopus and Web of Science?

Molecular Therapy Oncology is indexed in Web of Science, Scopus, DOAJ.